loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations
Open ICICI 3-in-1 Account

MARKETS TRADE HIGHER DURING MUHURAT SESSION, PHARMA STOCKS EXTEND WINNING STREAK

Published on Nov 08, 2026 15:15

Indian equity benchmarks continued to trade in positive territory during the special Muhurat trading session, supported by festive optimism and favourable domestic and global cues. The Nifty remained above the 25,000 mark, while pharmaceutical stocks continued their upward momentum, advancing for the fourth consecutive trading session.

At 3:10 p.m. IST, the S&P BSE Sensex was up 199.88 points, or 0.25%, at 81,227.90. The Nifty 50 gained 6.35 points, or 0.03%, to trade at 25,036.60.

Broader markets outperformed the frontline indices, with the BSE 150 MidCap Index rising 0.42% and the BSE 250 SmallCap Index advancing 1.39%.

Market breadth remained firmly positive. On the BSE, 3,161 shares advanced, while 798 declined and 215 remained unchanged.

Sectoral Spotlight: Pharma Stocks Extend Gains

The Nifty Pharma index climbed 1.47% to 28,402.90, extending its gains to 4.79% over four consecutive trading sessions.

Divi`s Laboratories led the sectoral gains, rising 5.11%. Piramal Pharma advanced 2.85%, followed by Sun Pharmaceutical Industries, which gained 2.60%. Wockhardt rose 2.32%, while Abbott India added 0.93%.

Other notable gainers included Laurus Labs (up 0.79%), Ajanta Pharma (up 0.49%), Torrent Pharmaceuticals (up 0.49%), Biocon (up 0.44%) and Zydus Lifesciences (up 0.43%).

Stocks in Spotlight

Tega Industries advanced 1.67%. The company reported a consolidated net loss of Rs 47.40 crore in Q2 FY27, compared with a net profit of Rs 44.94 crore in the corresponding quarter of the previous financial year. However, revenue from operations increased sharply to Rs 4,254.04 crore from Rs 405.35 crore in Q2 FY26.

Finolex Cables surged 19.21% after reporting strong Q2 FY27 financial results. Consolidated net profit jumped 67.8% year-on-year to Rs 272.92 crore, compared with Rs 162.64 crore in Q2 FY26. On a sequential basis, net profit grew 9.6% from Rs 249.04 crore in Q1 FY27.

Revenue from operations increased 65.0% year-on-year to Rs 2,269.33 crore from Rs 1,375.79 crore in the corresponding quarter last year. Sequentially, revenue rose 12.7% from Rs 2,013.15 crore in Q1 FY27.